 based on shared decision making and should be individualised after careful
weighting of the beneÔ¨Åts, harms, and costs. The LDL
(and other) treatment targets in the recommendation
should not be interpreted as absolute goals but more
as desired goals. Even if the goal is only partially met, it

can result in a marked reduction in cardiovascular events
in these very high risk people. Although very low LDL
levels are perhaps not achievable in all, LDL reductions
of up to 